CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
October 15, 2021 04:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
July 19, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
July 19, 2021 02:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
CLS Obtains EU Approval for New Thermometry Software Product, ThermoGuide, also Obtains Approval for Updated EC Certificate for Complete TRANBERG System including the Software
April 03, 2020 11:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, April 03, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it has obtained EU approval for its new thermometry software product, ThermoGuide, and...
University Hospital in Germany Evaluates CLS TRANBERG® | Laser Thermal Therapy System for Minimally Invasive Treatment of Small Liver Metastases and Tumors
March 18, 2020 11:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 18, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) today announced that the University Hospital in Magdeburg, Germany is evaluating the company’s MR-guided,...
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
June 14, 2019 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.; Immunophotonics, Inc.
ST. LOUIS and LUND, Sweden, June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (STO:CLS B) (CLS) today announced they have entered into a research...
CLS Presents Image-Guided Laser Immunotherapy System at 16th Annual Anglonordic Life Science Investor Conference
May 07, 2019 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
CEO Will Discuss New Products, Clinical Studies, and Industry Partners LONDON, May 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its TRANBERG® çThermal...
CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference
April 08, 2019 03:45 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, April 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today released a technical white paper regarding the company’s imILT® immuno-stimulating method for...
CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
March 25, 2019 03:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced that clinical studies and results for its imILT® heat-induced cancer immunotherapy for...